Results 91 to 100 of about 4,608 (197)

Re-Assembled Botulinum Neurotoxin Inhibits CNS Functions without Systemic Toxicity

Toxins, 2011
The therapeutic potential of botulinum neurotoxin type A (BoNT/A) has recently been widely recognized. BoNT/A acts to silence synaptic transmission via specific proteolytic cleavage of an essential neuronal protein, SNAP25.
Bazbek Davletov, Giampietro Schiavo, Dhevahi Niranjan, Ornella Rossetto, Michael H. Hastings, Marco Pirazzini, Matteo Caleo, Enrico Ferrari, Elizabeth S. Maywood, Laura Restani   +9 more
doaj   +1 more source

The therapeutic efficacy of post-symptom 3,4-diaminopyridine treatment in cosmetic injection-induced botulism using a novel animal model

Biomedical Technology
In recent years, the incidence of cosmetic injection-induced botulism has remarkably increased due to the frequent usage of botulinum neurotoxin type A (BoNT/A).
Ping He, Rongshuai Yan, Jie Liu, Pan You, Jianghe Zhang, Jinqing Li, Yiming Zhang   +6 more
doaj   +1 more source

Sectioned images and surface models of a cadaver head with reference to botulinum neurotoxin injection

, 2018
Background: The aim of this study is to elucidate the anatomical considerations with reference to botulinum neurotoxin type A (BTX) injection, on sectioned images and surface models, using Visible Korean.
Kim, B.C.; Department of Oral and Maxillofacial Surgery, Daejeon Dental Hospital, Wonkwang University College of Dentistry, Daejeon, Republic of Korea, Shin, D.S.; Department of Oral and Maxillofacial Surgery, Daejeon Dental Hospital, Wonkwang University College of Dentistry, Daejeon, Republic of Korea, Shim, Y.J.; Department of Oral Medicine, Daejeon Dental Hospital, Wonkwang University College of Dentistry, Daejeon, Republic of Korea   +2 more
core   +1 more source

Botulinum toxin type A - a treatment option for overactive and non-neurogenic detrusor overactivity (retrospective study)

, 2010
Objectives: Since the first therapeutic applications of botulinum toxin about 20 years ago, it has become an effective treatment for various indications including overactive and non-neurogenic detrusor overactivity.
Zachert, Katharina
core   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Effects of Botulinum Neurotoxin Type A on the Expression of Gephyrin in Cat Abducens Motoneurons

, 1998
In this study, we investigated the effects of long-term synaptic blockade on postsynaptic receptor clustering at central inhibitory glycinergic synapses. High doses of botulinum neurotoxin type A injected in the lateral rectus muscle completely abolishes
de la Cruz, Rosa R., Moreno-López, Bernardo, Alvarez, Francisco J., Delgado-García, Jose María, Pastor, Angel M.   +4 more
core   +1 more source

The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy

, 2014
BACKGROUND: The botulinum neurotoxin Type A (BTX) injection into the masseter muscle often causes a change in the facial expression. There is as yet no precise anatomic evidence to support this etiologic factor of constrained facial expressions ...
김희진, 최다예, 배정희, 이재기   +3 more
core   +1 more source

Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia

, 2019
Purpose: Urinary cytokines are proposed to predict urodynamic findings and outcome of intradetrusor botulinum neurotoxin type A injection in children with myelodysplasia.
TARCAN, TUFAN, ŞEKERCİ, ÇAĞRI AKIN, ŞİMŞEK, FERRUH, TANIDIR, YILÖREN   +3 more
core   +1 more source

Complications After Botulinum Neurotoxin Type A and Dermal Filler Injections: Data From a Large Retrospective Cohort Study

Aesthetic Surgery Journal, 2022
Steenen, Serge A., Bauland, Constantijn G., de Lange, Jan, van der Lei, Berend   +3 more
openaire   +2 more sources

Lameness improvement in horses with distal tarsal pain after intra-articular injection of botulinum neurotoxin type A

American Journal of Veterinary Research
Abstract Objective To evaluate the effect of IA injections of botulinum toxin type A (BoNT-A) in horses with chronic, naturally occurring distal tarsal osteoarthritis. Methods 9 horses were selected after physical and radiographic assessments. Horses also underwent an objective lameness examination and were included if they had a hindlimb impact ...
Antônio A. Beck, Letícia B. Paz, Maria I. Frank, Roberta C. F. Pereira, Flávio D. De La Côrte   +4 more
openaire   +2 more sources